Konferenzschrift | Kongress
Human tumour xenografts in anticancer drug development
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540186380
3540186387
9780387186382
0387186387
- Dimensions
-
29 cm
- Extent
-
XIV, 143 S.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Literaturangaben
- Keyword
-
Krebs
Heterotransplantation
Chemotherapie
Tiermodell
Krebs
Geschwulst
Zytostatika
Krebs
Tumor
Cytostatikum
- Event
-
Veröffentlichung
- (where)
-
Berlin, Heidelberg, New York, London, Paris, Tokyo
- (who)
-
Springer
- (when)
-
1988
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:13 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Konferenzschrift
- Kongress
Associated
- Winograd, Benjamin
- European School of Oncology
- Seminar on Human Tumour Xenografts (1986 : Mailand)
- Springer
Time of origin
- 1988
Other Objects (12)
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs
Neocarzinostatin : the past, present, and future of an anticancer drug
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs
Neocarzinostatin : the past, present, and future of an anticancer drug
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs